Lymphocyte Count and Body Mass Index as Biomarkers of Early Treatment Response in a Multiple Sclerosis Dimethyl Fumarate-Treated Cohort

Introduction: In relapsing Multiple Sclerosis (RMS) patients treated with disease modifying drugs (DMDs), few data are available regarding the biomarkers of treatment response. We aimed to assess the predictive value of lymphocyte count (LC) and Body Mass Index (BMI) for treatment response in a real...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Manni, Alessia, Iaffaldano, Antonio, Lucisano, Giuseppe, D'Onghia, Mariangela, Mezzapesa, Domenico Maria, Felica, Vincenzo, Iaffaldano, Pietro, Trojano, Maria, Paolicelli, Damiano
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587065/
https://ncbi.nlm.nih.gov/pubmed/31258529
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01343
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars